Mapping the scientific literature on reproductive health among transgender and gender diverse people: a scoping review

Abstract

We conducted a scoping review to map the extent, range and nature of the scientific research literature on the reproductive health (RH) of transgender and gender diverse assigned female at birth and assigned male at birth persons. A research librarian conducted literature searches in Ovid MEDLINE®, Ovid Embase, the Cochrane Library, PubMed, Google Scholar, Gender Studies Database, Gender Watch, and Web of Science Core Collection. The results were limited to peer-reviewed journal articles published between 2000 and 2018 involving human participants, written in English, pertaining to RH, and including disaggregated data for transgender and gender diverse people. A total of 2197 unique citations with abstracts were identified and entered into Covidence. Two independent screeners performed a title and abstract review and selected 75 records for full-text review. The two screeners independently extracted data from 37 eligible articles, which were reviewed, collated, summarised, and analysed using a numerical summary and thematic analysis approach. The existing scientific research literature was limited in terms of RH topics, geographic locations, study designs, sampling and analytical strategies, and populations studied. Research is needed that: focuses on the full range of RH issues; includes transgender and gender diverse people from the Global South and understudied and multiply marginalised subpopulations; is guided by intersectionality; and uses intervention, implementation science, and community-based participatory research approaches. Further, programmes, practices, and policies that address the multilevel barriers to RH among transgender and gender diverse people addressed in the existing scientific literature are warranted.

Introduction

In 1994, the International Conference on Population and Development (ICPD) defined reproductive health as “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity, in all matters relating to the reproductive system and to its functions and processes”.¹ The ICPD agreed on a broad definition of reproductive health that includes a quality and safe sex life, the opportunity to reproduce, and the autonomy to decide if, when, and how to pursue reproduction.^2,3 While some progress has been made, the reproductive health and rights of all groups – especially those who are socially and economically marginalised as a result of structural and interpersonal discrimination – have yet to be actualised.^4–6 In particular, transgender and gender diverse people – namely, people whose gender identity differs from social expectations based on their sex assigned at birth (e.g. transgender women, transgender men, non-binary, gender non-conforming, genderqueer, gender fluid, Two Spirit, and agender individuals) – experience pronounced barriers to reproductive health and rights as a result of bias, stigma, and discrimination within political, economic, social, education and healthcare structures and institutions.^7–9

Research shows that transgender and gender diverse assigned female at birth (AFAB) people (i.e. people assigned female at birth who identify as men, transgender men, masculine, transmasculine, non-binary, gender non-conforming, genderqueer, gender fluid, Two Spirit, and/or agender, among other identities) have various unmet reproductive health needs.^10,11 For instance, although transgender and gender diverse AFAB people can experience pregnancy,^12–14 they face notable barriers to contraception, including limited access to high-quality health care, a lack of healthcare provider training and competence in transgender health, cis- and hetero-normative healthcare provider assumptions, and gender identity-related bias, stigma, and discrimination in healthcare settings in particular, and society in general.^15–17 Similarly, research shows that transgender and gender diverse AFAB people are also less likely to obtain regular Pap tests compared to cisgender women (i.e. AFAB individuals who identify as women in terms of gender identity) as a result of institutional discrimination in healthcare systems, a lack of healthcare provider knowledge and training, and limited access to gender-affirming care.¹⁸

Additionally, although many transgender and gender diverse AFAB people have expressed an interest in pregnancy, childbearing, and parenthood,^19–21 studies indicate that they also face notable challenges in these areas, including limited access to gender-affirming fertility preservation and assisted reproduction services and erasure, stigma, and discrimination in the reproductive healthcare system in particular and society in general.^5,7,9,22 Similarly, transgender and gender diverse assigned male at birth (AMAB) individuals (i.e. people assigned male at birth who identify as women, transgender women, feminine, transfeminine, non-binary, gender non-conforming, genderqueer, gender fluid, Two Spirit, and/or agender, among other identities) also experience notable challenges to becoming parents. Indeed, although many transgender and gender diverse AMAB people report a desire to have children,^21,23,24 they experience significant barriers in accessing and utilising fertility preservation and assisted reproduction services, including a lack of gender-affirming healthcare providers and organisations that competently and respectfully address their fertility intentions and desires and reproductive health needs and concerns.^23–25

To our knowledge, the extent, scope, and nature of research on the reproductive health of transgender and gender diverse AFAB and AMAB people has yet to be characterised. Therefore, we conducted a scoping review to systematically identify, ascertain, and summarise the research literature on the reproductive health of transgender and gender diverse AFAB and AMAB individuals.^26–28 The results of this scoping review will allow us to make recommendations for future research, practice, and policy on reproductive health among transgender and gender diverse people, with the goal of advancing the reproductive health and rights of this structurally marginalised and medically underserved population.

Methods

Scoping reviews are an approach to knowledge synthesis that incorporates a range of study designs and uses rigorous, systematic, and transparent methods to map the extent, range, and nature of the research literature on a given topic, summarise research findings on this topic, and identify research gaps in the existing literature with the goal of informing future research, policy, and practice.^27,28 The purpose of our scoping review was to determine the range and nature of and identify research gaps in the scientific literature on transgender and gender diverse individuals’ reproductive health. We sought to answer the following research question: What is known and what is not known from the scientific literature about the reproductive health needs and experiences of transgender and gender diverse AFAB and AMAB people? We then identified, selected, charted, and summarised relevant studies using the methodological framework proposed by Arksey and O’Malley.²⁷ Our approach also incorporated Levac et al.’s²⁶ adaptations to the Arksey and O’Malley²⁷ framework, including linking the scoping review purpose and research question, using an iterative team-based approach to study selection and data extraction with multiple reviewers, and incorporating both a numerical summary and thematic analysis in the summary and reporting of research findings.

Specifically, a research librarian conducted literature searches for relevant articles in Ovid MEDLINE®, Ovid Embase, the Cochrane Library, PubMed, Google Scholar, Gender Studies Database, Gender Watch, and Web of Science Core Collection. Final searches were performed in all databases on November 7, 2018. Databases were searched using a combination of controlled vocabulary and free text terms (Appendix A). The Yale MeSH Analyzer (http://mesh.med.yale.edu) was used in the initial stages of strategy formulation to harvest controlled vocabulary and keyword terms from relevant known articles included in the MEDLINE database. The results were limited to peer-reviewed journal articles; case reports, commentaries, editorials, newspaper articles, literature or systematic reviews, reports, committee opinions, clinical guidelines, and letters were filtered out. Peer-reviewed journal articles were included if they were published between 2000 and 2018, involved human participants, were written in English, pertained to a reproductive health topic, and disaggregated data for transgender and gender diverse people (rather than, for example, presenting aggregate data for lesbian, gay, bisexual, transgender, and queer [LGBTQ] individuals combined). Only studies pertaining to transgender and gender diverse people’s own reproductive health experiences, preferences, concerns, needs, or priorities were included. In contrast, papers that focused on others’ (e.g. health care providers’, family members’) views and experiences pertaining to the reproductive health of transgender and gender diverse people or on transgender and gender diverse people’s reproductive organs or cells rather than their reproductive health outcomes or experiences, were excluded (Table 1).

Table 1.

Study inclusion and exclusion criteria

Inclusion Criteria	Exclusion Criteria
English Language	Non-English Language
Human Studies	Animal Studies
Published from 2000 to 2018	Published prior to 2000
Peer-reviewed journal article	Non peer-reviewed publication
Empirical research study (quantitative or qualitative)	Non-empirical research study (i.e. case report, editorial, commentary, newspaper article, literature or systematic review, report, committee opinions, clinical guidelines, letter)
Study pertains to one or more of the following outcomes: reproductive health, reproductive health care, gynaecology, obstetrics, pregnancy, contraception, abortion, fertility intentions, reproduction, family planning, birth, assisted reproduction, IVF, surrogacy, prenatal care, postnatal care, gynaecologic cancers, cervical cancer, fertility	Study does not pertain to reproductive health
Study disaggregates data for transgender and gender diverse people	Study does not disaggregate data for transgender and gender diverse people
Study pertains to transgender and gender diverse people’s own reproductive health experiences, preferences, concerns, needs, or priorities (as opposed to other’s views and experiences or organs or cells)	Study does not pertain to transgender and gender diverse people’s own reproductive health experiences, preferences, concerns, needs, or priorities (e.g. focuses on other’s views and experiences or on organs or cells)

Citations from all databases were imported into an EndNote X9 library. Duplicate citations were removed in Endnote, and final citations and their abstracts were entered into Covidence, a screening and data extraction tool.²⁹ Two independent screeners performed a title and abstract review on all citations based on the inclusion and exclusion criteria (Table 1). The first author resolved any disagreement on study inclusion (e.g. whether a study had disaggregated data for transgender and gender diverse people, whether a study addressed transgender and gender diverse people’s own reproductive health views and experiences vs. others’ such as their parents) between the screeners. Through this process, the screeners and first author selected records for full-text review, from which the two screeners independently extracted data on study characteristics (i.e. year, country, study design, methodology, methods, and sampling strategy), sample characteristics (i.e. number of transgender and gender diverse study participants and distributions of sex assigned at birth, gender identity, age, race/ethnicity, and educational attainment) and reproductive health topic.

The data extraction form was developed collaboratively by the screeners and first author, tested independently by the two screeners using a subset of the articles, and revised iteratively during the data extraction process. The standard data extraction form in Covidence was supplemented to capture additional study characteristics of interest to the research team, including study samples’ gender identity, racial/ethnic, socioeconomic, and age composition. The two independent screeners and the first author reviewed all the extracted data, and all discrepancies (mostly related to study type, sample size, and participant demographic characteristics) between the screeners were resolved by discussion and consensus. The agreed upon extracted data were reviewed, collated, and analysed by the first author in collaboration with the screeners and served as the basis for the results presented in this article. Specifically, they grouped the studies by reproductive health topic, characterised the study population, study design, and sample characteristics for each one, identified research gaps in the scientific literature, and summarised the studies’ main findings using both a numerical summary and thematic analysis approach.^26,27 Of note, our scoping review did not include a formal quality assessment of each study, which is not a required component of this approach. However, we globally ascertained to what extent the existing literature provided valid, generalisable, and actionable information on the reproductive health of transgender and gender diverse people.^26–28

Results

Our search strategy generated a total of 5861 citations. Duplicate citations were removed, reducing the total number of citations to 2197. The title and abstract review of these citations yielded 75 records for full-text review. A total of 38 articles were excluded from full-text review for not being empirical research (n = 11), having the wrong outcomes (n = 10), being duplicates (n = 7), conference abstracts (n = 3), study protocols (n = 2), or case reports (n = 1), and not disaggregating data for transgender and gender diverse individuals (n = 4; Figure 1).

Figure 1.

PRISMA flow chart. Adapted from Moher et al.⁵⁵

Of the 37 articles included in the full-text review (Appendix B), Table 2 shows that the vast majority (n = 34, 91.9%) were published after 2013, with a steady increase in the number of articles published between 2014 (n = 4, 10.8%) and 2018 (n = 10, 27.0%). Moreover, most studies were conducted in the United States (n = 25, 67.6%), followed by Canada (n = 6, 16.2%), Australia (n = 2, 5.4%), Belgium (n = 2, 5.4%), Sweden (n = 1, 2.7%) and Germany (n = 1, 2.7%). Further, almost all (n = 36, 97.3%) studies were observational and relied on convenience or purposive sampling strategies (n = 36, 97.3%). Of note, we only identified one (2.7%) intervention research study and one (2.7%) study that utilised a (sub-national) probability sample. Additionally, most studies used quantitative (n = 15, 40.5%), followed by qualitative (n = 13, 35.1%), research methodologies. Approximately one quarter (n = 9, 24.3%) used a mixed-methods research approach that combined both quantitative and qualitative data and two (5.4%) adopted a participatory research methodology. In terms of methods, the majority of studies utilised cross-sectional surveys (n = 17, 46.0%) and/or in-depth interviews (n = 17, 45.9%), followed by clinical chart reviews (n = 7, 18.9%; Table 2).

Table 2.

Study characteristics of included articles (N = 37)

Characteristic	n	%
Year
Pre-2014	3	8.1
2014	4	10.8
2015	4	10.8
2016	7	18.9
2017	9	24.3
2018	10	27.0
Country
United States	25	67.6
Canada	6	16.2
Australia	2	5.4
Belgium	2	5.4
Sweden	1	2.7
Germany	1	2.7
Study design
Observational	36	97.3
Intervention	1	2.7
Methodology*
Quantitative	15	40.5
Qualitative	13	35.1
Mixed-methods	9	24.3
Participatory/CBPR	2	5.4
Methods*
Chart review	7	18.9
Cross-sectional survey	17	45.9
Longitudinal survey	0	0.0
In-depth interviews	17	45.9
Focus groups	1	2.7
Clinical examinations	2	5.4
Clinical interviews	1	2.7
Sampling
Convenience/purposive	36	97.3
Probability	1	2.7

*Categories are not mutually exclusive.

   Note: Percentages may not add to 100% due to non-mutually exclusive categories and rounding error.

Table 3 shows that the majority (n = 27, 73.0%) of studies relied on samples including fewer than 125 transgender and gender diverse participants. Additionally, most (n = 23, 62.2%) articles included in the full text review solely pertained to the reproductive health of AFAB individuals, including transgender men, transmasculine individuals, and gender diverse AFAB people. Approximately one third (n = 13, 35.1%) included both transgender and gender diverse AFAB and AMAB participants (of which only n = 5, 13.5% included disaggregated study results), while only one (2.7%) study exclusively focused on the reproductive health needs and experiences of AMAB participants. Further, none of the studies included in the full-text review solely pertained to non-binary and other gender diverse individuals, whose needs and experiences were addressed in conjunction with (n = 20, 54.1%) and rarely disaggregated from (n = 2, 5.4%) those of transgender individuals with binary gender identities. Moreover, the vast majority (n = 31, 83.8%) of articles pertained to young and midlife adults, with only three (8.1%) addressing adolescent reproductive health and none addressing the reproductive health concerns of older adults. Almost all studies that specified their sample’s racial/ethnic (n = 24, 64.9%) and educational (n = 17, 45.9%) composition included a majority of White (n = 24/24, 100%) and college-educated (n = 16/17, 94.1%) transgender and gender diverse participants, with no disaggregation of study findings by race/ethnicity or educational attainment in any study (Table 3). Moreover, of the studies that reported the racial/ethnic breakdown of participants at all or beyond the proportion of White participants (n = 23, 62%), most included only small numbers of Black, Latinx, Asian, Native Hawaiian/Pacific Islander, and multiracial individuals. Of note, only four (17%) studies reported including Native, Indigenous, or Aboriginal people (data not shown).

Table 3.

Sample characteristics of included articles (N = 37)

Characteristic	n	%
Sample size*
1–24	11	29.7
25–49	8	21.6
50–74	4	10.8
−99	1	2.7
100–124	3	8.1
≥125	10	27.0
Sex assigned at birth
Assigned female at birth (AFAB) only	23	62.2
Assigned male at birth (AMAB) only	1	2.7
Both AFAB and AMAB	13
Aggregated	8	21.6
Disaggregated	5	13.5
Gender identity
Transgender only	15	40.5
Gender diverse only	0	0.0
Both transgender and gender diverse	22
Aggregated	20	54.1
Disaggregated	2	5.4
Life stage
Adolescents (< 18 years) only	3	8.1
Adults (≥ 18 years) only	31	83.8
Both adolescents and adults
Aggregated	1	2.7
Disaggregated	1	2.7
Not specified	1	2.7
Race/ethnicity: White (%)
<49	0	0.0
50–74	13	35.1
75–100	11	29.7
Not specified	13	35.1
Educational attainment: some college or more (%)
<25	0	0.0
25–49	1	2.7
50–74	2	5.4
75–100	14	37.8
Not specified	20	54.1

*Pertains to number of transgender and gender diverse study participants only.

   Note: Percentages may not add to 100% due to rounding error.

Further, we found that the articles included in the full-text review addressed a variety of reproductive health topics and sub-topics (Table 4). The topic addressed in the largest number of studies was cervical cancer screening (n = 14, 37.8%), including cervical cancer screening results (n = 2, 5.4%), frequency (n = 6, 16.2%), perceptions, attitudes and preferences (n = 6, 16.2%), experiences (n = 4, 10.8%), and performance (n = 1, 2.7%). Other commonly examined topics were fertility, (n = 10, 27.0%) including fertility desires, intentions, and attitudes (n = 8, 21.6%) and fertility services use and experiences (n = 2, 5.4%); and fertility preservation (n = 8, 21.6%) namely, fertility preservation counselling or consultation (n = 3, 8.1%), fertility preservation services use and experiences (n = 5, 13.5%), and fertility preservation knowledge and attitudes (n = 4, 10.8%). Other less commonly studied topics were pregnancy (n = 7, 18.9%), reproductive health care (in general; n = 2, 5.4%), contraceptive use (n = 3, 8.1%), birth (n = 5, 13.5%), cervical cancer risk perceptions and treatment experiences (n = 2, 5.4%), parenthood experiences (n = 1, 2.7%), and chest feeding experiences (n = 1, 2.7%; Table 4).

Table 4.

Reproductive health topic of included articles (N = 37)

Topic	n	%
Fertility preservation	8	21.6
Counselling/consultation	3	8.1
Services use/experiences	5	13.5
Knowledge/attitudes	4	10.8
Pregnancy	7	18.9
Risk	1	2.7
Outcomes	1	2.7
Experiences	4	10.8
Involvement	1	2.7
Contraceptive use	3	8.1
Fertility	10	27.0
Desires/intentions/attitudes	8	21.6
Services use/experiences	2	5.4
recommendations	1	2.7
Cervical cancer screening	14	37.8
Results	2	5.4
Frequency	6	16.2
Perceptions/attitudes/preferences	6	16.2
Experiences	4	10.8
Performance	1	2.7
Cervical cancer	2	5.4
Risk perceptions	1	2.7
Treatment experiences	1	2.7
Reproductive health care	2	5.4
Needs	2	5.4
Experiences	2	5.4
Research priorities	1	2.7
Interest	1	2.7
Birth	5	13.5
Outcomes	1	2.7
Experiences	2	5.4
Parenthood experiences	1	2.7
Chest-feeding experiences	1	2.7
Abortion care	0	0.0

Note: Percentages may not add to 100% due to non-mutually exclusive categories and rounding error.

In general, researchers found that transgender and gender diverse AFAB and AMAB people faced notable barriers to achieving their fertility intentions and desires due to a lack of access to reproductive health services, including fertility preservation, reproduction assistance, pregnancy-related care, and contraception, that addressed their unique and specific needs. Additionally, when utilising reproductive health services pertaining to pregnancy, birth, contraception and cervical cancer screening, transgender and gender diverse individuals experienced several barriers to obtaining high-quality care, including cost,^25,30,31 a lack of health care provider knowledge of and training in transgender reproductive health,^5,11,30 non-inclusive and non-affirming clinical environments and practices,^5,6,12,32 and gender identity bias, stigma, and discrimination in reproductive healthcare settings and in patient–provider interactions.^{7,12,15,19,30} Moreover, several studies found that gender dysphoria (i.e. distress due to persistent feelings of conflict between one’s gender identity and sex assigned at birth) also posed a challenge to accessing and utilising reproductive health care,^10,13,32 which is often branded as “women’s health care”, among many transgender and gender diverse AFAB individuals.

Discussion

The results of this scoping review suggest several significant gaps in the scientific research literature addressing the reproductive health of transgender and gender diverse AFAB and AMAB people. Although we found that the number of studies focusing on this topic increased between 2010 and 2018, the scientific literature on the reproductive health needs and experiences of transgender and gender diverse people was heavily weighted towards particular countries, study designs, study populations, reproductive health topics, and sampling and analytical strategies. Of note, the majority of studies were conducted in the Global North, especially the United States, and were observational and cross-sectional in nature. In terms of study population, most studies pertained to transgender and gender diverse AFAB individuals, with few articles devoted to or inclusive of transgender and gender diverse AMAB people. Similarly, no study exclusively focused on gender diverse (e.g. non-binary, gender fluid, gender non-conforming, genderqueer, agender) people and almost all of those that included both transgender and gender diverse participants aggregated the data for these distinct gender identity groups.

Further, the scientific literature on the reproductive health of transgender and gender diverse individuals has focused on a small number of topics, especially cervical cancer screening but also pregnancy, fertility preservation, and fertility intentions, desires, and attitudes. In contrast, topics such as contraceptive use and birth have received much less attention, and no study pertained to abortion care among transgender and gender diverse people. In terms of sampling and analytical strategies, the vast majority of studies relied on small, convenience or purposive samples of predominately White, college-educated, and young and midlife adult transgender and gender diverse people. Additionally, among the studies that included both transgender and gender diverse people, very few presented results disaggregated by gender identity, and no study disaggregated their research findings by age, race/ethnicity, or socioeconomic position. Therefore, the existing literature does not address the full range of reproductive health topics relevant to transgender and gender diverse people or accurately reflect the reproductive health concerns and experiences of AMAB people, gender diverse people, Black, Latinx, Indigenous, and Asian/Pacific Islander people, poor or low-income people, or adolescents.

To continue expanding the small but growing scientific literature on the reproductive health of transgender and gender diverse people, researchers should broaden the reproductive health topics and populations included. Specifically, future studies should address the full range of reproductive health issues relevant to transgender and gender diverse people, including contraceptive use, abortion care, and birth. Further, additional reproductive health studies should be conducted among not only AFAB but also AMAB transgender and gender diverse people from across the globe, including the Global South, with data disaggregated by gender identity and other social categories as feasible. Further, studies that adopt longitudinal and probability sampling research approaches are needed to facilitate causal inference, capture reproductive health concerns across the life course, and promote the generalisability of research findings to transgender and gender diverse people overall.³³ Of note, existing cross-sectional (e.g. National Survey of Family Growth, Demographic Health Surveys) and longitudinal (e.g. National Longitudinal Study of Adolescent to Adult Health) national probability sample surveys that address reproductive health topics should include validated gender identity measures and oversample transgender and gender diverse people.^34,35 Additionally, population-based transgender health studies (e.g. TransPOP Study) should collect detailed information on various reproductive health outcomes over time.

To adequately reflect the reproductive health needs, preferences, and experiences of multiply marginalised transgender and gender diverse people – including but not limited to gender diverse people, Black, Indigenous, Latinx, and Asian/Pacific Islander people, adolescents, and poor and low-income individuals – scientific research on the reproductive health of transgender and gender diverse people should be guided by intersectionality. Intersectionality is an analytical framework rooted in Black feminist theory and practice that posits that the lived experiences of individuals and social groups are simultaneously shaped by multiple and mutually constitutive forms of discrimination and oppression, including but not limited to racism, sexism, transphobia and cisgenderism, heterosexism, and classism as linked to White supremacy, patriarchy, colonialism, and capitalism.^36–39 Of note, intersectionality suggests that multiply marginalised transgender and gender diverse people have different and unique health needs and experiences from those who occupy privileged social, economic, and political positions.⁴⁰ Similarly, empirical research has identified disparities in various health and health care outcomes among transgender and gender diverse people by gender identity, race/ethnicity, socioeconomic position, sexual orientation, and age.^7,41,42 Health disparities related to nativity, disability, and other social determinants of health are also likely among transgender and gender diverse people,⁴³ although they have not yet been documented in the scientific literature. Thus, research that is guided by intersectionality is urgently needed to promote the reproductive health and rights of all transgender and gender diverse people, including those who are multiply marginalised as a result of not only transphobia and cisgenderism but also racism, classism, heterosexism, age, xenophobia, and ableism, among other dimensions of social stratification and inequality.

Despite the need for probability sample surveys that generate generalisable estimates of reproductive health outcomes among transgender and gender diverse people, quantitative, qualitative, and mixed-methods research studies that rely on purposive sampling strategies will continue to be necessary to ensure the generation of meaningful research findings for multiply marginalised transgender and gender diverse people. In line with an intersectional approach, researchers can use various purposive sampling strategies, including quota sampling and respondent driven, participant referral, or snowball sampling, to ensure that their reproductive health studies include multiply marginalised transgender and gender diverse populations, who are underrepresented in the general population, in sufficient numbers to generate meaningful results for these subpopulations.^44,45 Investigators can also use intersectionality throughout the research process to ensure that their research teams, research questions, and data collection, analysis, and interpretation efforts centre the lived experiences of diverse groups of transgender and gender diverse people at the intersection of multiple forms of social inequality.^40,45–47 In particular, future studies should include transgender and gender diverse individuals from diverse social backgrounds on their research teams, measure multiple dimensions of not only social identity (e.g. gender identity, race/ethnicity, sexual orientation) but also discrimination (e.g. transphobia, racism, heterosexism) at both the interpersonal and structural level, analyse study results in relation to multiple dimensions of social identity and inequality, both within and across subpopulations, and interpret research findings in their social and historical context.^40,45–47

Intersectionality can also guide researchers not only to generate research findings to increase knowledge but also to develop, test, implement, and disseminate interventions that promote the reproductive health and rights of transgender and gender diverse people using intervention research, implementation science, and community-based participatory research (CBPR) approaches. In particular, researchers should develop and test interventions that address barriers to and facilitators of reproductive health among transgender and gender diverse people, including those who are multiply marginalised, at multiple levels of influence, including the individual (e.g. knowledge, risk perceptions), interpersonal (e.g. patient–provider communication), institutional (e.g. gender-affirming procedures and protocols), community (e.g. community norms), and societal (e.g. health and social policies) levels.⁴⁸ Further, implementation science can help scientists identify and address the factors that influence both the implementation and dissemination of these interventions to ensure that they are tailored to and address the specific and unique needs of transgender and gender diverse people from various social backgrounds and geographic locations.⁴⁹ Finally, CBPR, which provides a collaborative approach to research that equitably involves community members in all phases of the process to inform action on a given population health issue and its social determinants,⁵⁰ is particularly well aligned with intersectionality, which seeks to advance social justice by linking both theory and practice and addressing power imbalances.⁴⁷ Studies that use this collaborative and equitable approach are needed to ensure that research informs programmes, practices, and policies that address the reproductive health needs of transgender and gender diverse people, including those who are multiply marginalised, as they define them for themselves.⁵⁰

The studies included in our scoping review have important implications for not only research but also practice and policy. Specifically, healthcare providers should receive ongoing training in transgender and gender diverse reproductive health, person-centered care, gender-affirming care, transphobia, cisgenderism, and other forms of bias, stigma and discrimination in health care, structural competence, and shared decision-making in order to facilitate access to and utilisation of high-quality reproductive health care that is inclusive and respectful of transgender and gender diverse people’s lived experiences and reproductive health needs. Further, reproductive healthcare settings can be more welcoming to transgender and gender diverse people by avoiding branding reproductive health as “women’s health care,” ensuring that facilities are visibly inclusive and affirming of transgender and gender diverse people, providing educational materials that are inclusive of transgender and gender diverse individuals, designing intake forms that use gender-affirming language and response options, training all front desk and health care staff to use patients’ correct names and pronouns, and providing patients with opportunities to report (and then addressing) biased, stigmatising, or discriminatory treatment.^17,51–53 Additionally, because transgender and gender diverse people may prefer receiving reproductive health care in community settings that are especially tailored to their needs, community-based organisations that serve transgender and gender diverse people should receive the funding, support, and technical assistance they need from state and local health departments and health care institutions to deliver reproductive health services.⁵⁴

The results and implications of our scoping review should be understood in the context of several limitations. First, our findings only pertain to empirical research studies written in English and published in peer-reviewed journals. As such, they may not be applicable to studies published in other languages and in other formats or venues (e.g. reports, briefs, theses, dissertations, websites), which may differ in important ways from the English-language scientific research literature. Additionally, the results of our scoping review findings only apply to the 2000–2018 period. As such, they may not reflect the scientific literature published before 2000 or after 2018. Therefore, future scoping reviews pertaining to transgender and gender diverse people’s reproductive health should seek to include studies written in languages other than English, include both the scientific and grey literature, and consider a longer time period, as feasible given available resources.

The existing scientific literature represents an important first step in describing the reproductive health of transgender and gender diverse people. However, our scoping review shows that this literature is limited in terms of geographic regions represented, reproductive health topics addressed, methods used, and populations included. As a result, existing scientific research does not reflect the full range of reproductive health issues that are relevant to transgender and gender diverse people and may not be generalisable to those who are multiply marginalised or living in the Global South. Moreover, research that uses an intersectional approach is needed to promote our understanding of how multiple forms of social inequality influence the reproductive health of transgender and gender diverse people from various social backgrounds, both within and across subpopulations defined in relation to race/ethnicity, gender identity, socioeconomic position, age, nativity and disability, among other social categories. Lastly, investigators should conduct studies that use intervention research, implementation science, and CBPR approaches to develop, test, implement, and disseminate programmes, practices, and policies that collaboratively address transgender and gender diverse people’s reproductive health concerns as they define them for themselves. Together, these efforts will help ensure that the reproductive health and rights of all transgender and gender diverse people are understood and addressed with dignity and respect.

Appendices.

Appendix A. Search strategy

Search for Ovid MEDLINE®

Searches for additional databases available upon request (alyssa.grimshaw@yale.edu)

1. (trans$gender* or trans$sex* or trans$women or trans$woman or trans$men or trans$man or trans$feminine or trans$masculine or trans$person* or trans$girl or trans$boy or trans$girls or trans$boys or transex* or trans$spectrum).mp.

2. (koti or hijra or mahuvahine or mahu or waria or katoey or bantut or nadleehi or berdache or xanith).mp.

3. (two spirit* or third gender* or third sex or gender variant* or gender queer or blended spirit or non$binary or gender diverse or sex* divers* or gender expansive or gender cross* or cross gender or gender incongruen* or gender dysphor*).mp.

4. (male-to-female and MtF).mp.

5. (female-to-male and FtM).mp.

6. (gender adj3 non$conform*).mp.

7. exp transgender persons/ or exp health services for transgender persons/ or exp transsexualism/ or exp gender dysphoria/

8. 1 or 2 or 3 or 4 or 5 or 6 or 7

9. exp Reproductive Health Services/ or exp Reproductive Health/ or exp Women’s Health/ or exp Reproductive Rights/ or exp Fertility Preservation/ or exp Reproductive Techniques/ or exp Infertility/ or exp Fertility/ or exp Genital Neoplasms, Female/

10. exp oocyte retrieval/ or exp embryo transfer/ or exp ovulation induction/ or exp cryopreservation/ or exp Semen preservation/

11. exp Fertilization in Vitro/ or exp Pregnancy/ or exp Pregnancy Outcome/ or exp Pregnancy Complications/

12. (reproductive health or reproductive service* or women’s health or women’s service* or women’s care or gynecologic care).mp.

13. (fertil* or contraception* or abort* or pregnan* or family plan* or assisted reproduction or IVF or surrog* or prenatal care or postnatal care or preconception care or delivery or miscarr* or egg* freez* or sperm freez* or egg preserv* or sperm preserv* or in vitro fertilization or cytopreserv* or uterine transplant*).mp.

14. ((endomet* or cervical or uterus or uterine or gynecolog*) and (cancer* or neoplasm* or carinoma*)).mp.

15. 9 or 10 or 11 or 12 or 13 or 14

16. 8 and 15

17. limit 16 to english language

18. limit 17 to yr=“2000 – Current”

19. limit 18 to (case reports or comment or editorial or letter)

20. 18 not 19

21. exp animals/

22. exp animals/ and exp humans/

23. 21 not 22

24. 20 not 23

Appendix B. Table of included studies (N = 37)

Year	First Author (Last Name)	Title	Journal	Country
2018	Adkins	Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia	Cytopathology	United States
2016	Agénor	Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives	Culture, Health & Sexuality	United States
2018	Agénor	Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults	Journal of General Internal Medicine	United States
2017	Armuand	Transgender men’s experiences of fertility preservation: a qualitative study	Human Reproduction	Sweden
2018	Auer	Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study	Journal of Sexual Medicine	Germany
2018	Charter	The transgender parent: Experiences and constructions of pregnancy and parenthood for transgender men in Australia	International Journal of Transgenderism	Australia
2017	Chen	Fertility Preservation for Transgender Adolescents	Journal of Adolescent Health	United States
2018	Chen	Attitudes Toward Fertility and Reproductive Health Among Transgender and Gender-Nonconforming Adolescents	Journal of Adolescent Health	United States
2017	Cipres	Contraceptive use and pregnancy intentions among transgender men presenting to a clinic for sex workers and their families in San Francisco	Contraception	United States
2002	De Sutter	The desire to have children and the preservation of fertility in transsexual women: A survey	International Journal of Transgenderism	International
2008	Dutton	Gynecologic care of the female-to-male transgender man	Journal of Midwifery & Women’s Health	United States
2015	Ellis	Conception, pregnancy, and birth experiences of male and gender variant gestational parents: it’s how we could have a family	Journal of Midwifery & Women’s Health	United States
2017	Hoffkling	From erasure to opportunity: A qualitative study of the experiences of transgender men around pregnancy and recommendations for providers	BMC Pregnancy and Childbirth	United States
2015	James-Abra	Trans people’s experiences with assisted reproduction services: a qualitative study	Human Reproduction	Canada
2016	Johnson	Qualitative study of cervical cancer screening among lesbian and bisexual women and transgender men	Cancer Nursing	United States
2016	Johnson	Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men	Journal of Clinical Nursing	United States
2016	Jones	Fertility preservation in transgender patients	International Journal of Transgenderism	Canada
2014	Light	Transgender men who experienced pregnancy after female-to-male gender transitioning	Obstetrics & Gynecology	International
2018	Light	Family planning and contraception use in transgender men	Contraception	United States
2016	MacDonald	Transmasculine individuals’ experiences with lactation, chestfeeding, and gender identity: A qualitative study	BMC Pregnancy and Childbirth	International
2017	McDowell	Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests	LGBT Health	United States
2017	Nahata	Low Fertility Preservation Utilization Among Transgender Youth	Journal of Adolescent Health	United States
2014	Peitzmeier	Female-to-Male Patients Have High Prevalence of Unsatisfactory Paps Compared to Non-Transgender Females: Implications for Cervical Cancer Screening	Journal of General Internal Medicine	United States
2014	Peitzmeier	Pap test use is lower among female-to-male patients than non-transgender women	American Journal of Preventive Medicine	United States
2017	Peitzmeier	“It Can Promote an Existential Crisis”: Factors Influencing Pap Test Acceptability and Utilization Among Transmasculine Individuals	Qualitative Health Research	United States
2016	Porsch	An Exploratory Study of Transgender New Yorkers’ Use of Sexual Health Services and Interest in Receiving Services at Planned Parenthood of New York City	Transgender Health	United States
2018	Reisner	Test performance and acceptability of self-versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients	PLoS One	United States
2014	Ross	Sexual and gender minority peoples’ recommendations for assisted human reproduction services	Journal of Obstetrics & Gynaecology Canada: JOGC	Canada
2017	Seay	Understanding Transgender Men’s Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey	LGBT Health	United States
2018	Strang	Transgender Youth Fertility Attitudes Questionnaire: Measure Development in Nonautistic and Autistic Transgender Youth and Their Parents	Journal of Adolescent Health	United States
2018	Tabaac	Gender Identity Disparities in Cancer Screening Behaviors	American Journal of Preventive Medicine	United States
2015	Taylor	Cancer’s Margins: Trans and Gender Nonconforming People’s Access to Knowledge, Experiences of Cancer Health, and Decision-Making	LGBT Health	International
2017	Tornello	Cancer’s Margins: Trans and Gender Nonconforming People’s Access to Knowledge, Experiences of Cancer Health, and Decision-Making	LGBT Health	United States
2016	Veale	Prevalence of Pregnancy Involvement Among Canadian Transgender Youth and its Relation to Mental Health, Sexual Health, and Gender Identity	International Journal of Transgenderism	Canada
2015	von Doussa	Imagining parenthood: the possibilities and experiences of parenthood among transgender people	Culture, Health & Sexuality	Australia
2012	Wierckx	Reproductive wish in transsexual men	Human Reproduction	Belgium
2018	Wingo	Reproductive Health Care Priorities and Barriers to Effective Care for LGBTQ People Assigned Female at Birth: A Qualitative Study	Women’s Health Issues	United States

Disclosure statement

No potential conflict of interest was reported by the author(s).